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ABSTRACT
Primary vesicoureteral reflux (pVUR) is one of the most common causes of pediatric kidney failure. Linkage
scans suggest that pVUR is genetically heterogeneous with two loci on chromosomes 1p13 and 2q37 under
autosomal dominant inheritance. Absence of pVUR in parents of affected individuals raises the possibility of
a recessive contribution to pVUR.We performed a genome-wide linkage scan in 12 large families segregating
pVUR, comprising 72 affected individuals. To avoid potential misspecification of the trait locus, we performed
a parametric linkage analysis using both dominant and recessive models. Analysis under the dominant model
yielded no signals across the entire genome. In contrast, we identified a unique linkage peak under the
recessive model on chromosome 12p11-q13 (D12S1048), which we confirmed by fine mapping. This interval
achieved a peak heterogeneity LOD score of 3.6 with 60% of families linked. This heterogeneity LOD score
improved to 4.5 with exclusion of two high-density pedigrees that failed to link across the entire genome. The
linkage signal on chromosome 12p11-q13 originated from pedigrees of varying ethnicity, suggesting that
recessive inheritance of a high frequency risk allele occurs in pVUR kindreds frommany different populations.
In conclusion, this study identifies a major new locus for pVUR and suggests that in addition to genetic
heterogeneity, recessive contributions should be considered in all pVUR genome scans.
J Am Soc Nephrol 20: 1633–1640, 2009. doi: 10.1681/ASN.2008111199
Vesicoureteral reflux (VUR; OMIM no. 193000) is
the retrograde flow of urine from the bladder to the
ureters and the kidneys duringmicturation.Uncor-
rected, VUR can lead to repeated urinary tract in-
fections, renal scarring and reflux nephropathy, ac-
counting for up to 25% of pediatric end stage renal
disease.1,2 VUR is commonly seen as an isolated disor-
der (primary VUR; pVUR), but it can also present in
associationwithcomplexcongenitalabnormalitiesofthe
kidney and urinary tract or with specific syndromic
disorders, such as renal-coloboma and branchio-oto-
renal syndromes.3–8
pVUR has a strong hereditary component,
with monozygotic twin concordance rates of
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80%.9–12 Sibling recurrence rates of 30% to 65% have
suggested segregation of a single gene or oligogenes with
large effects.9,12–14 Interestingly however, the three pub-
lished genome-wide linkage scans of pVUR have strongly
suggested multifactorial determination.15–17 Two pVUR
loci have been identified with genome-wide significance
on chromosomes 1p13 and 2q37 under an autosomal dom-
inant transmission with locus heterogeneity.15,16 Multiple
suggestive signals have also been reported, but remarkably,
these studies show little overlap.15–17 These data suggest
that pVUR may be extremely heterogeneous, with muta-
tions in different genes each accounting for a fraction of
cases. The genes underlying pVUR loci have not yet
been identified, but two recent studies
have reported segregating mutations in
the ROBO2 gene in up to 5% of pVUR
families.18,19
Despite evidence for genetic hetero-
geneity and different subtypes of disease,
genetic studies have all modeled pVUR
as an autosomal dominant trait.15–17,20
Recessive inheritance has generally not
been considered because the absence of
affected parents can be explained by
spontaneous resolution of pVUR with
older age. However, many pVUR cohorts
are composed of affected sibships or
pedigrees compatible with autosomal re-
cessive transmission, suggesting the po-
tential for alternative modes of inheri-
tance.9–12,16,17,20–22 Systematic family
screening to clarify the mode of inheri-
tance is not feasible for pVUR because
the standard diagnostic tool, the voiding
cystourethrogram (VCUG), is invasive
and would expose participants to radia-
tion. Formal assessment of a recessive
contribution in sporadic pVUR has also
been difficult because studies have been
conducted in populations with low con-
sanguinity rates.9–12,16,17,20–22 However,
recent studies have identified an unex-
pected recessive contribution to several
complex traits such as ductus arteriosus
or autism.23,24 Thus, in addition to ge-
netic heterogeneity, genes with alterna-
tive modes of transmission may segre-
gate among pVUR families, and
misspecification of the inheritance
model may complicate mapping studies
of this trait.
Several approaches can be considered
to address the difficulties imposed by com-
plex inheritance, variable penetrance, and
genetic heterogeneity. Studying large,
well characterized cohorts with newer single-nucleotide
polymorphism (SNP)-based technologies can maximize in-
heritance information across the genome and increase the
power of linkage studies.25 In addition, in the setting of
locus heterogeneity and uncertainty about the mode of
transmission, analysis under a dominant and a recessive
model has greater power compared with nonparametric
methods and more often results in detection of the correct
mode of transmission without incurring a significant pen-
alty for multiple testing.26–29 We combined these ap-
proaches in this study and successfully localized a major
gene for VUR, which unexpectedly demonstrates autosomal
recessive transmission.
Figure 1. Pedigree structure of the 16 families studied. Asterisks (*) mark the individ-
uals from whom DNA was available for the study. Patients with other urinary tract (UT)
anomalies are indicated by a blackened rectangle within the symbol.
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RESULTS
We identified 16 large Caucasian pedigrees from the United
States (n 8) and Italy (n 8) ascertained through an index
case with pVUR documented by positive VCUG and obtained
DNA from 200 individuals (Figure 1 and Supplemental Table
S1). Of the United States kindreds, six were of Hasidic Jewish
origin (K117, K120, K122, K138, K144, K146), and twowere of
Irish American origin (K118, K119). Among the 184 relatives
of the probands, 56 individuals (30%) had pVUR based on a
positive VCUGwithout other renal or urologic defects, and 11
individuals (6%) had urinary tract abnormalities other than
pVUR (Supplemental Table S1). The prevalence of pVUR and
other urinary tract abnormalities among relatives was approx-
imately 30-fold and 60-fold higher, respectively, than the re-
ported prevalence in the general population.14,30 These data are
consistent with the known familial aggregation of pVUR and
other urinary tract defects, indicating a strong genetic effect on
these traits. The remaining 117 individuals were considered as
phenotype unknown. Based on our primary phenotype of
pVUR without other urologic abnormalities, 12 families were
informative for linkage (72 affected individuals, 22 males and
50 females). If individuals with non pVURurinary tract defects
were also considered as affected, all 16 families were informa-
tive (broad pVURphenotype, 83 affected individuals, 28males
and 55 females).
Interpretation of modes of inheritance in pVUR is compli-
cated as a result of incomplete penetrance of the trait as well as
spontaneous resolution of disease with increasing age. Exami-
nation of the pedigree structure revealed that seven families
(44%) demonstrated parent-child transmission, suggestive of
autosomal dominant inheritance. Absence of parent-child
transmission in the remaining families was compatible either
with dominant transmission with incomplete penetrance or
recessive transmission of a high frequency gene. In the setting
of genetic heterogeneity and uncertain mode of inheritance,
parametric, LOD-based analysis under two simple models
(dominant and recessive) is more powerful than allele sharing
linkagemethods.26–28 Therefore, our primary analysis was per-
formed by computing heterogeneity LOD scores under both
dominant and recessive models, using pVUR as our primary
phenotype (12 informative families: K108, K110, K113, K116,
K117, K118, K119, K120, K122, K138, K144, K146).
As with previous pVUR genome scans, analysis under ge-
netic homogeneity did not identify any significant linkages un-
der the dominant or recessive models.15–17 Under genetic het-
erogeneity and dominant transmission, the highest genome-
wide heterogeneity LOD (HLOD) was on chromosome 8
(multipoint HLOD  1.7,   0.6, nonparametric linkage
[NPL]  1.3, P  0.05). However, after saturating this locus
with 16 microsatellite markers, the HLOD decreased to zero.
Combining microsatellite with SNP data has been shown to
increase information content and improve the resolution of
genome scans.25 Therefore, to exclude low marker informa-
tiveness as a cause of false negative results, we performed ge-
nome-wide SNP genotyping (Affymetrix 10K arrays) in 95 in-
dividuals in the most informative families. This analysis did
not reveal novel loci across the genome, indicating that the
absence of linkage under the dominantmodel is not due to lack
of marker informativeness. Post hoc analysis of the seven ped-
igrees with parent-child transmission also did not reveal any
promising signals. Hence, we found no significant or sugges-
tive loci across the genome under the dominant model (sup-
plemental Figure S1).
In contrast, heterogeneity analysis under the recessive
model identified a single promising signal on chromosome 12
Table 1. Pairwise HLOD scores for Chr12 p11-q13
Marker Mb
pVUR
Phenotype
Broad pVUR
Phenotype
rs2054436 21.5 0.9 0.7
rs725124 23.7 0.7 0.4
D12S1591 24.0 2.2 1.2
TSC54265 25.1 0.5 0.8
D12S1596 25.8 1.5 1.2
rs2343866 26.2 0.2 0.0
rs1388659 27.1 0.4 0.3
TA27A06P 27.5 0.6 0.2
D12S1643 29.2 1.4 0.7
rs958478 29.3 0.1 0.0
D12S1681 30.4 0.9 0.3
D12S1584 31.6 0.7 0.1
D12S345 33.0 2.6 1.9
D12S2080 33.3 0.9 0.4
rs1352123 37.4 0.6 0.9
rs721709 39.0 1.6 1.4
D12S1048 39.3 1.8 1.5
rs2215456 40.6 1.6 0.9
D12S1589 40.7 1.6 1.5
D12S291 41.7 2.8 2.8
rs721483 42.0 0.2 0.3
TA91H06M 42.4 0.8 0.5
D12S1687 43.0 1.3 0.7
rs1377002 43.2 0.3 0.2
D12S85 45.6 0.3 0.2
rs215389 46.1 1.3 1.4
rs2254210 46.6 0.3 0.3
D12S2196 47.0 1.3 1.2
rs953673 47.4 1.4 1.1
D12S1627 48.1 1.9 1.7
rs4133070 48.4 1.6 1.8
rs1316607 49.3 0.9 1.2
D12S361 49.8 1.6 2.2
D12S1712 50.7 2.0 1.9
UT5029 50.9 1.3 1.4
rs686339 51.3 0.1 0.1
D12S398 51.5 3.8 3.1
D12S1586 52.4 1.6 1.6
D12S1707 53.3 1.0 1.2
rs2371455 55.1 0.5 0.6
D12S1644 55.8 1.0 0.4
Bolded numbers indicate HLOD scores 2. Broad phenotype includes
individuals with pVUR or other urinary tract abnormalities.
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with an HLOD of 1.4 on pairwise analysis (D12S297,  
0.64). Multipoint analysis augmented the HLOD to 2.7 across
this interval (  0.65, peak at D12S1301). Importantly, this
was the only peak with multipoint HLOD2 across the entire
genome under either the dominant or recessive model (Sup-
plemental Figures S1 and S2). To confirm this finding, we per-
formed high resolution mapping with 22 additional microsat-
ellite markers and combined these with the SNP
data, resulting in a mean intermarker distance of
0.77 Mb across the chromosome 12p11-q13 re-
gion. We observed positive pairwise HLODs
across all markers within this interval, including
one marker with genome-wide significance
(D12S398, HLOD  3.8,   0.82, Table 1).31
Next, multipoint analysis of linkage confirmed
these results (multipoint HLOD 3.6 at marker
D12S1048,   0.6, Figure 2A). This result ex-
ceeds traditional genome-wide significance
thresholds.31,32 Furthermore, based on 1000 sim-
ulated genome-scans of the pedigrees under the
assumption of no linkage, the empiric genome-
wide significance thresholds for testing twomod-
els under genetic heterogeneitywere 2.7 and 3.3 at
P 0.05 and 0.01, respectively. The HLOD of 3.6
therefore corresponds to an empiric genome-
wide P value of 0.005, confirming genome-wide
significance of findings by empiric criteria. The
LOD-1 interval spans 22.7 Mb between markers
rs1388659 and D12S361 and includes 161 genes.
We next performed comparison of haplotypes
across the chromosome 12 linkage regions to ex-
plore the possibility of a founder mutation, but found no evi-
dence of shared segments among Hasidic or among Italian
pedigrees (Supplemental Table S2). However, since these ped-
igrees were not closely related, the shared segments may be
below the resolution of our typed markers.
Alternative analyses were also performed to determine
whether varyingmodel parameters, analytic algorithm,orpheno-
type assignment impacted the chromosome 12 linkage results.
Examination of pedigree LOD scores revealed that both Hasidic
and nonHasidic pedigrees contributed to the linkage signal on
chromosome 12. In addition, multipoint analysis in the six Ha-
sidic Jewish pedigrees using marker allele frequencies from eth-
nicity matched controls revealed a peak HLOD of 2.6 (marker
D12S291,  0.6). This further confirmed that most, but not all
of the linkage signal originated from this subgroup (Table 2).
Varying gene frequency (0.01 to 0.1) had negligible effects on
overall linkage findings, with the best LOD scores achieved by
modeling a high frequency risk allele (Table 3). Nonparametric
analyses were also conducted and yielded a NPL score of 4.0 and
P 1 104 (at D12S1301), which falls just below the genome-
wide significance threshold. Finally, to determine the impact of a
broader phenotype assignment, we repeated the linkage analysis
after including as affected all individualswithother renal anduro-
Table 2. Peak multipoint LOD scores for each individual
pedigree at the chromosome 12p11-q13
Pedigree Ethnicity
LOD
pVUR
Phenotype
LOD
Broad
Phenotype
120 Ashkenazi Jewish 1.9 1.9
138 Ashkenazi Jewish 1.5 1.5
119 Irish-American 1.0 1.0
108 Italian 0.8 0.8
116 Italian 0.5 -1.0
146 Ashkenazi Jewish 0.5 0.5
144 Ashkenazi Jewish 0.1 0.1
110 Italian -0.5 -0.5
113 Italian -0.6 -0.6
118 Irish-American -0.7 -0.7
117 Ashkenazi Jewish -1.2 -1.2
122 Ashkenazi Jewish -1.4 -1.6
143 Italian N.I. 0.6
140 Italian N.I. 0.1
141 Italian N.I. -0.1
102 Italian N.I. -0.4
Broad phenotype includes individuals with pVUR or other urinary tract
abnormalities. N.I., pedigree is not informative for pVUR phenotype.
Table 3. Peak multipoint HLOD scores at chromosome
12p11-q13 with varying disease gene frequency
Disease Gene Frequency 0.01 0.05 0.10
HLOD (), pVUR phenotype 3.4 (0.7) 3.6 (0.6) 3.4 (0.65)
HLOD (), broad pVUR phenotype 3.2 (0.6) 3.4 (0.5) 3.0 (0.5)
Broad pVUR phenotype includes individuals with pVUR or other urinary tract
abnormalities. The  value indicates the percent of families linked.
Figure 2. (A) HLOD plot of chromosome 12p11-q13 locus in the full cohort. The
multipoint HLOD scores for the pVUR and broad pVUR phenotypes are shown on
the y-axis. The x-axis denotes Mb distance based on the NCBI human physical map
build 36.3. The location of themicrosatellite markers genotyped is shown above the
graph. The LOD-1 interval is indicated by the horizontal bar above the HLOD curve.
(B) HLOD plot after post hoc exclusion of K117 and K122.
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logic clinical disorders. This expanded the cohort to 16 pedigrees
and 83 affected individuals. Despite the broader phenotype, link-
age to chromosome 12p11-q13 was confirmed, with a peak
HLOD score of 3.4 ( 0.5, Figure 2A). This locus remained the
only suggestive or significant signal across the genome under ei-
ther phenotype assignment scheme,with thenext bestmultipoint
HLOD score being 1.0 on chromosome 8. Altogether, these data
demonstrate that the chromosome 12 linkage results were robust
tovaryinganalyticparameters andphenotypeassignmentcriteria.
Finally, we scrutinized the genome in two large families
(K117 and K122) that did not demonstrate linkage to chromo-
some 12 and were each large enough to achieve genome-wide
significance (LOD3). Remarkably, there was no evidence for
linkage across the entire genome in either kindred under both
dominant and recessive inheritance, even after incorporation
of genome-wide SNPs intomicrosatellite data. The best signals
were multipoint LOD scores of 1.3 with the dominant model
on chromosome 8 (D8S592) for K117 and 1.2 with the reces-
sive model for K122 on chromosomes 2 (SraP) and 10
(D10S1412), which are all below the suggestive significance
threshold. Given the large size of these pedigrees and the com-
prehensive analyses performed across the genome, the absence
of any linkage signals cannot be attributed to genetic heteroge-
neity or low power. These data suggest that problems such as
complex structure or bilineal inheritance likely confound the
analysis of linkage in these pedigrees. Because these two pedi-
grees did not map anywhere across the genome and conse-
quently could only obscure linkage signals in our study, we
performed post hoc analysis of the chromosome 12 locus after
exclusion of these two complex kindreds (Figure 2B). This re-
sulted in HLOD scores of 4.5 (  0.8) and 4.1 (  0.7) on
chromosome 12p11-q13 for the pVUR and broad pVUR phe-
notypes, respectively (Figure 2B). Significantly, the remaining
four Hasidic Jewish pedigrees demonstrate a LOD score of 3.9
with genetic homogeneity across the same region, indicating
that most of the linkage signal originates from this subgroup
(Figure 2B).
DISCUSSION
In the present study, we combined multiple approaches to
overcome problems such as complex inheritance, incomplete
penetrance, and genetic heterogeneity to localize pVUR sus-
ceptibility loci. Instead of studying sib pairs with nonparamet-
ric methods, we ascertained uniquely large families and ana-
lyzed the genome under both dominant and recessive
transmission, because this approach avoids potentialmisspeci-
fication of the geneticmodel andmaximizes power in the anal-
ysis of complex traits.26,29 The genome scan under the domi-
nant model provided no signals across the entire genome. On
the other hand, analysis under a recessive model localized a
major susceptibility gene to an approximately 22-Mb interval
on chromosome 12p11-q13, with a peak HLOD score of 3.6
( 0.6, NPL 4.0, P 1 104). This linkage peak was the
only positive signal across the entire genome, exceeding ge-
nome-wide and empiric significance thresholds, and was not
significantly changed by alternative analytic models or incor-
poration of a broader phenotype. These data emphasize the
utility of parametric models for detection of major genes un-
derlying complex traits.
The localization of a major gene with the recessive model
may seem surprising because the literature has primarily fo-
cused on VUR segregating as a dominant trait.15,16,19,33–35 The
absence of disease transmission across multiple generations
has usually been attributed to incomplete penetrance or unde-
tectable VUR due to spontaneous resolution in older individ-
uals. However, given that many pVUR families consist of af-
fected sib pairs, and considering the high degree of genetic
heterogeneity of this trait, it is likely that genes with different
modes of inheritance segregate among different pVUR pedi-
grees. The lack of parent-offspring transmissionmay therefore
represent true recessive inheritance in some kindreds. Low
penetrance recessive alleles imparting large effects have been
implicated in several other complex traits such as patent duc-
tus arteriosus,Hirschsprung disease, or autism.23,24,36 For these
traits, gene localization was achieved by homozygosity map-
ping in consanguineous populations that were enriched for
recessive disorders.23,24,36,37 Although we did not set out to
study consanguineous populations, our cohort included six
Hasidic Jewish kindreds, which contributed a significant pro-
portion (but not all) of the linkage signal on chromosome 12
(Figure 2B). This population hasmany characteristics of a clas-
sic isolate, such as a limited set of founders, high endogamy,
and recent expansion.38,39 In such a population, a common
predisposing allele can achieve a high frequency due to founder
effects, selection, or drift, enhancing the probability of reces-
sive disorders.39,40 However, because several other pedigrees
also contributed to the chromosome 12 linkage signal, these
data suggest that recessive transmission applies to pVUR fam-
ilies of varying ethnicity.
The complexity of pVUR is further demonstrated by the
lack of compelling signals across the genome in two high-den-
sity Hasidic Jewish kindreds (K117 and K122). These kindreds
contained a total of 21 pVUR cases and were each predicted to
be large enough to exceed LOD3 under dominant (K117 and
K122) or recessive (K117)models. Thus, the absence of linkage
cannot be attributed to low power and genetic heterogeneity.
Moreover, phenotyping error is unlikely, since all affecteds had
VCUG-documented VUR. Such high-density pedigrees are
commonly enriched for intrafamilial heterogeneity (the situa-
tion where affected individuals in a family have different risk
alleles in the same gene or different genetic forms of disease).41
Therefore, the most likely alternative explanation is that these
pedigrees have a complex hidden genealogical structure, such
that risk alleles segregate across multiple lines of descent. This
is a common phenomenon in population isolates, and the
presence of all affected sibships in K117 would further support
this possibility. Although intrafamilial heterogeneity reduces
power in linkage analysis of complex traits, it does not produce
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false positive signals nor necessarily lead to false exclusion of
linkage.41 The effects of such confounders can be mitigated by
studying large cohorts and applying systematic analytic ap-
proaches, as demonstrated by the successful localization of a
pVUR gene in our study.
There are 161 genes in the conservative LOD-1 interval on
the chromosome 12 p11-q13 locus (National Center for Bio-
technology Information [NCBI] Map Viewer). Among these,
19 genes have been implicated in human traits (OMIM). Based
on a recently published study, 83 positional candidates have
murine homologs and detectable expression in the murine
metanephricmesenchyme and ureteric bud tip and stalk (Sup-
plemental Table S3).42 These positional candidates may be
pursued by systematic sequence analysis; however, it would be
preferable to achieve further reduction of this locus through an
interval-specific association study.43–45 Since the post hoc anal-
ysis indicated a strong linkage signal with homogeneity among
the Hasidic Jewish families, association mapping may be espe-
cially suitable in this population because of its limited number
of founders.38,39,46,47 Furthermore, one would expect enrich-
ment for homozygous segments surrounding susceptibility
genes among pVUR cases from this population. We did not
detect regions of homozygosity within the chromosome 12 lo-
cus in the Hasidic Jewish patients, but this may be due to the
lack of close consanguinity among families studied. Therefore,
a higher resolution analysis may be required to detect autozy-
gous segments in these kindreds.
These findings have many important implications for fu-
ture genetic studies of pVUR. Because the chromosome 12
signal originated from pedigrees of varying ethnicity, recessive
transmission may be applicable to pVUR kindreds frommany
different populations. Thus, in addition to genetic heterogene-
ity, variable modes of transmission should be considered in all
pVUR linkage scans, and analysis under recessive transmission
is henceforth warranted. It is also worth noting that sporadic
disease cannot be differentiated from recessive transmission in
the absence of an affected family member or consanguinity.
Consequently, the recessive contribution to pVUR may have
been underestimated in nonfamilial cases as well. If recessive
transmission accounts for a significant fraction of sporadic
pVUR, this offers a potentially powerful setting for a genome-
wide association study. As demonstrated by recent studies of
age-related macular degeneration, modest sized case/control
cohorts may be quite successful in such situations.48 Thus, as-
sociation scans in sporadic pVUR may offer an additional
promising approach for resolving the genetic basis of this trait.
CONCISE METHODS
Patients and Phenotypes
All families were ascertained through an index case diagnosed with
primary VUR by a VCUG. Index cases and family members had no
evidence of secondary causes of VUR or syndromic abnormalities. In
addition, we conducted extensive family history interviews and
searched medical records to identify family members diagnosed with
pVUR documented by VCUG or any clinical or urologic abnormali-
ties that may be pathogenically related to pVUR (e.g., other urologic
anomalies or a diagnosis of ESRD in absence of any obvious cause
such as glomerulonephritis and/or diabetes mellitus). This led to the
identification of 56 relatives with pVUR and 11 relatives with other
renal or urologic abnormalities (Supplemental Table S1). For linkage
analysis, we considered all individuals with pVUR diagnosed with
VCUG as affected, leaving all others as phenotype unknown. Subse-
quently, we performed linkage analysis by also including the 11 addi-
tional family members with clinically related abnormalities in the
affected cohort. Because VUR is known to resolve with age, we classi-
fied individuals that did not undergo a VCUG and those with a neg-
ative VCUG as phenotype unknown in all analyses (affected only
analysis). All individuals gave informed consent, and the study pro-
tocol adhered to the Declaration of Helsinki and was approved by the
Western Institutional Review Board for Columbia University and the
ethics committees at the University of Brescia and at the Gaslini In-
stitute.
Genotyping
Total genomic DNAwas isolated from peripheral white blood cells of
the patients and relatives using standard procedures. We performed
genome-wide scans using both microsatellites and SNPs. The micro-
satellite scan was performed with 393 microsatellites (intermarker
distance approximately 10 cM) genotyped across the genome in all
200 individuals (Marshfield Mammalian Genotyping Service). To
maximize inheritance information across the genome, we also typed
95 individuals (65 affecteds) in themost complex families with 10,204
SNPs using the GeneChips Mapping 10K 2.0 Arrays (Affymetrix,
Santa Clara, California). DNA processing and gene-chip hybridiza-
tion were performed as suggested by the manufacturer. We fine-
mapped two loci suggestive of linkage on chromosome 8 and chro-
mosome 12 (with 16 and 22 polymorphic microsatellite markers,
respectively). Integration of the most informative SNPs from 10K
GeneChip data (minor allele frequency [MAF] 0.2) with the fine
mapping microsatellites on the chromosome 12 locus yielded an av-
erage marker spacing of 0.77 Mb and average information content of
0.9 (standard deviation 0.1).
Analysis of Linkage
We performed pairwise and multipoint analyses of linkage, using
FASTLINK4.1,49 and SimWalk2 2.90,50 respectively. Since pVUR is
known to be genetically heterogeneous, we computed parametric
LOD scores under a dominant and a recessive model, with disease
gene frequencies of 0.01 and 0.05, respectively.We used penetrance of
75% and phenocopy of 0.01 for both models (since affected only
analysis was performed, penetrance parameters did not affect LOD
statistics). For comparison, we concurrently computed nonparamet-
ric statistics with the SimWalk2 program (NPLpairs score and associ-
ated exact P value).We calculated allele frequencies on the basis of the
frequencies observed in the dataset for the genome-wide microsatel-
lites, whereas for the SNP data, we based frequencies on Caucasian
allele frequencies provided by Affymetrix. In the fine mapping exper-
iments, we obtained control allele frequencies from40Ashkenazi Jew-
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ish individuals. We used published thresholds for significant linkage
under heterogeneity (LOD  3.3).31,32 Moreover, we estimated em-
piric thresholds of significance by performing 1000 genome scans
with microsatellites spaced every 10 cM across the genome under the
hypothesis of no linkage, using the same structure as our pedigrees,
and performing pairwise genome scans under the dominant and re-
cessive models described above.
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